0000899243-21-044658.txt : 20211115 0000899243-21-044658.hdr.sgml : 20211115 20211115185944 ACCESSION NUMBER: 0000899243-21-044658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UNITED BIOMEDICAL INC CENTRAL INDEX KEY: 0000896839 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 211413450 BUSINESS ADDRESS: STREET 1: 25 DAVIDS DR CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: 631-273-2828 MAIL ADDRESS: STREET 1: 25 DAVIDS DR CITY: HAUPPAUGE STATE: NY ZIP: 11788 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-15 0 0001851657 Vaxxinity, Inc. VAXX 0000896839 UNITED BIOMEDICAL INC 25 DAVIDS DRIVE HAUPPAUGE NY 11788 0 0 1 0 Class A common stock 2021-11-15 4 C 0 247050 A 51585416 D Class A common stock 2021-11-15 4 C 0 4212495 A 4212495 I Held by United Biomedical Inc., Asia Series A preferred stock 2021-11-15 4 C 0 384410 D Class A common stock 247050 0 D Series A preferred stock 2021-11-15 4 C 0 6554643 D Class A common stock 4212495 0 I Held by United Biomedical Inc., Asia Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest. /s/ Mei Mei Hu, As Director and Officer 2021-11-15